anti- IL-6 antibody

Este producto es parte de IL6 - Interleukin 6
anti- IL-6 antibody

Pida mas información

935106861

info@markelab.com

Precio

Precio a consultar

Antibody anti-IL6

proveedor

FineTest

reference

FNab04282

Tested Applications

ELISA, WB, IHC, IF

reactivity

human,mouse,rat

status

RUO

clonality

polyclonal

Descripción

Interleukin-6(IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. IL-6 protein is secreted by a variety of cell types including T cells and macrophages as phosphorylated and variably glycosylated molecule. IL-6 Plays an essential role in the final differentiation of B-cells into Ig-secreting cells involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. IL-6 is also considered a myokine, a cytokine produced from muscle, and is elevated in response to muscle contraction. IL-6 has been shown to interact with interleukin-6 receptor and glycoprotein 130. Additionally, IL-6 is involved in hematopoiesis, bone metabolism, and cancer progression, and has been defined an essential role in directing transition from innate to acquired immunity.


Background

IL6 is a pleiotropic cytokine involved in regulating immune responses, inflammation, and hematopoiesis It is produced by macrophages, T cells, fibroblasts, and endothelial cells in response to infections, trauma, or tissue damage IL6 activates downstream signaling through its receptor, IL-6R, and the JAK/STAT3 pathway, driving acute-phase protein synthesis, such as CRP and fibrinogen, and promoting B cell differentiation into plasma cells Dysregulated IL6 expression is associated with chronic inflammation, autoimmune diseases like rheumatoid arthritis, and cancer progression, where it promotes tumor growth, survival, and angiogenesis IL6 also contributes to cytokine storm syndrome in conditions like COVID-19, where excessive IL6 leads to hyperinflammation and organ damage Targeting IL6 signaling with anti-IL6 therapies, such as tocilizumab, has shown efficacy in treating autoimmune diseases and cytokine-driven conditions

Características del producto

category

Primary Antibodies


clonality

polyclonal


reactivity

human,mouse,rat


immunogen target

interleukin 6(interferon, beta 2)


host

Rabbit


isotype

IgG


conjugation

Unconjugated


form

liquid


tested applications

ELISA, WB, IHC, IF


observerd MW

24 kDa


purity

≥95% as determined by SDS-PAGE


purification

Immunogen affinity purified


recommended dilution

WB: 1:500-1:1000; IHC: 1:50-1:200; IF: 1:50-1:200


size 1

100µg


storage

PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)


or code

IL6


alias

IL-6,BSF,HGF,HSF,IFNB2,CDF,B-cell stimulatory factor 2


note

This product is for research use only.


Quizá le pueda interesar

Human HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

Human HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

proveedor

FineTest

reference

AQ-H0201

reactivity

human

status

RUO

Precio a consultar

Ver más

Human HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

Human HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

proveedor

FineTest

reference

AQ-H0201-B

reactivity

human

status

RUO

Precio a consultar

Ver más

Mouse HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

Mouse HS-IL-6(High sensitive Interleukin 6) Accquant® ELISA Kit

proveedor

FineTest

reference

AQ-M0121-B

reactivity

mouse

status

RUO

Precio a consultar

Ver más